Skip to main content.

Stephen Hyter, PhD

Stephen Hyter portrait
Clinical Assistant Professor, Pathology and Laboratory Medicine

Professional Background

Doctor Hyter is a member of the Godwin Laboratory and serves as the Assistant Director of the Clinical Molecular Oncology Laboratory (CMOL) in the Division of Genomics Diagnostics. He received his undergraduate degree from the University of Kansas, doctorate degree at Oregon State University and postdoctoral fellowship at the University of Kansas Medical Center.

Education and Training
  • BGS, History, University of Kansas
  • PhD, Molecular and Cellular Biology, Oregon State University
  • Post Doctoral Fellowship, Ovarian Cancer, University of Kansas Medical Center



His research interests include skin homeostasis, ovarian cancer genetic signatures and bioinformatics. .

  • Braun, M., W, Abdelhakim, H, Li , M, Hyter, S, Pessetto, Z, Koestler, D., C, Pathak, H., B, Dunavin, N, Godwin, A., K. 2020. Adherent cell depletion promotes the expansion of renal cell carcinoma infiltrating T cells with optimal characteristics for adoptive transfer.. Journal for immunotherapy of cancer, 8 (2)
  • Blidner, R., A, Haynes, B., C, Hyter, S, Schmitt, S, Pessetto, Z., Y, Godwin, A., K, Su, D, Hurban, P, van Kempen, L., C, Aguirre, M., L, Gokul, S, Cardwell, R., D, Latham, G., J. 2019. Design, Optimization, and Multisite Evaluation of a Targeted Next-Generation Sequencing Assay System for Chimeric RNAs from Gene Fusions and Exon-Skipping Events in Non-Small Cell Lung Cancer.. The Journal of molecular diagnostics : JMD, 21 (2), 352-365
  • Hirst, J, Pathak, H., B, Hyter, S, Pessetto, Z., Y, Ly, T, Graw, S, Koestler, D., C, Krieg, A., J, Roby, K., F, Godwin, A., K. 2018. Licofelone Enhances the Efficacy of Paclitaxel in Ovarian Cancer by Reversing Drug Resistance and Tumor Stem-like Properties.. Cancer research, 78 (15), 4370-4385
  • Pessetto, Z., Y, Chen, B, Alturkmani, H, Hyter, S, Flynn, C., A, Baltezor, M, Ma, Y, Rosenthal, H., G, Neville, K., A, Weir, S., J, Butte, A., J, Godwin, A., K. 2017. In silico and in vitro drug screening identifies new therapeutic approaches for Ewing sarcoma.. Oncotarget, 8 (3), 4079-4095
  • Do, T., V, Hirst, J, Hyter, S, Roby, K., F, Godwin, A., K. 2017. Aurora A kinase regulates non-homologous end-joining and poly(ADP-ribose) polymerase function in ovarian carcinoma cells.. Oncotarget, 8 (31), 50376-50392